Currently predicting for Thu, 4 Jun 2026

ABBV Prediction Chart

ABBV Predictions History

Latest community submissions for ABBV.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Jan 18, 2022 $136.37 -0.30% $136.78 X 99.70% 5
Jan 18, 2022 Bullish $136.78 X 1
JS JS Pro
Jan 13, 2022 $137.64 +3.09% $133.52 X 96.91% 0
tmax619 tmax619 @tmax619.149365
Jan 13, 2022 Bullish $133.52 X 0
JS JS Pro
Oct 26, 2021 Bullish $109.49 X 1
JS JS Pro
Oct 26, 2021 $108.71 -0.71% $109.49 X 99.29% 4
AlexVel AlexVel Pro
Oct 26, 2021 $107.91 -1.44% $109.49 X 98.56% 1
Oct 26, 2021 Bullish $109.49 X 1
Jul 12, 2021 Bullish $117.63 X 1
Jun 2, 2021 $112.21 +0.73% $111.40 X 99.27% 4
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABBV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABBVIE INC
AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE